KTRA logo

Kintara Therapeutics (KTRA) Selling, General & Administrative Expenses

Annual SG&A

$5.79 M
+$303.00 K+5.52%

01 June 2024

1-Year Change

+5.52%
KTRA annual selling, general & administrative expenses is up +5.52% year-on-year

3-Year Change

-40.68%
KTRA annual selling, general & administrative expenses is down -40.68% over the past 3 years

All-time High

$9.76 M
KTRA annual selling, general & administrative expenses is currently -40.68% below its historical high of $9.76 million
Annual Total Expenses$8.45 M
KTRA annual total expenses is $8.45 million
Annual Operating Expenses$8.45 M
KTRA annual total operating expenses is $8.45 million
Annual Net Income-$8.32 M
KTRA annual net profit is -$8.32 million

KTRA Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly SG&A

$2.28 M
+$791.00 K+52.98%

01 June 2024

1-Year Change

+107.07%
KTRA quarterly selling, general & administrative expenses is up +107.07% year-on-year

3-Year Change

+4.87%
KTRA quarterly selling, general & administrative expenses is up +4.87% over the past 3 years

All-time High

$2.79 M
KTRA quarterly selling, general & administrative expenses is currently -18.25% below its historical high of $2.79 million
Quarterly Total Expenses$2.38 M
KTRA quarterly total expenses is $2.38 million
Quarterly Operating Expenses$2.38 M
KTRA quarterly total operating expenses is $2.38 million
Quarterly Net Income-$2.32 M
KTRA quarterly net profit is -$2.32 million

KTRA Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM SG&A

-$627.48 M
-$8.50 M-1.37%

01 June 2024

1-Year Change

-12372.15%
KTRA TTM selling, general & administrative expenses is down -12372.15% year-on-year

3-Year Change

-6133.41%
KTRA TTM selling, general & administrative expenses is down -6133.41% over the past 3 years

All-time High

$10.40 M
KTRA TTM selling, general & administrative expenses is currently -6133.41% below its historical high of $10.40 million
Annual Total Expenses$8.45 M
KTRA annual total expenses is $8.45 million
Annual Operating Expenses$8.45 M
KTRA annual total operating expenses is $8.45 million
TTM Net Income-$8.32 M
KTRA TTM net profit is -$8.32 million

KTRA TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KTRA Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.5%+107.1%-10000.0%
3 y3 years-40.7%+4.9%-6133.4%
5 y5 years+22.2%+149.9%-10000.0%

KTRA Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-40.7%-18.3%-6133.4%

Kintara Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
June 2024
$5.79 M(+5.5%)
$2.28 M(+53.0%)
$5.79 M(+21.2%)
Mar 2024
-
$1.49 M(+64.4%)
$4.78 M(+4.3%)
Dec 2023
-
$908.00 K(-17.7%)
$4.58 M(-10.4%)
Sept 2023
-
$1.10 M(-13.4%)
$5.11 M(-6.8%)
June 2023
$5.49 M(-27.0%)
$1.27 M(-1.9%)
$5.49 M(-3.2%)
Mar 2023
-
$1.30 M(-9.9%)
$5.67 M(-9.4%)
Dec 2022
-
$1.44 M(-2.4%)
$6.25 M(-8.1%)
Sept 2022
-
$1.48 M(+1.4%)
$6.81 M(-9.4%)
June 2022
$7.51 M(-23.0%)
$1.45 M(-22.8%)
$7.51 M(-13.9%)
Mar 2022
-
$1.88 M(-5.5%)
$8.72 M(-9.1%)
Dec 2021
-
$1.99 M(-8.5%)
$9.60 M(-7.7%)
Sept 2021
-
$2.18 M(-18.3%)
$10.40 M(+6.6%)
June 2021
$9.76 M(+116.1%)
$2.67 M(-3.5%)
$9.76 M(+14.0%)
Mar 2021
-
$2.76 M(-1.1%)
$8.56 M(+24.5%)
Dec 2020
-
$2.79 M(+82.1%)
$6.87 M(+33.9%)
Sept 2020
-
$1.53 M(+4.4%)
$5.13 M(+13.7%)
June 2020
$4.51 M(-4.7%)
$1.47 M(+36.4%)
$4.51 M(-9.4%)
Mar 2020
-
$1.08 M(+2.2%)
$4.98 M(+2.9%)
Dec 2019
-
$1.05 M(+15.3%)
$4.84 M(+3.8%)
Sept 2019
-
$914.00 K(-52.9%)
$4.66 M(-1.5%)
June 2019
$4.74 M(+17.2%)
$1.94 M(+107.3%)
$4.74 M(+20.6%)
Mar 2019
-
$935.50 K(+6.9%)
$3.93 M(-5.3%)
Dec 2018
-
$874.90 K(-11.3%)
$4.15 M(-3.2%)
Sept 2018
-
$986.50 K(-12.7%)
$4.28 M(+6.0%)
June 2018
$4.04 M(+21.8%)
$1.13 M(-2.1%)
$4.04 M(+11.0%)
Mar 2018
-
$1.16 M(+14.1%)
$3.64 M(+14.3%)
Dec 2017
-
$1.01 M(+35.9%)
$3.19 M(+16.1%)
Sept 2017
-
$744.60 K(+1.8%)
$2.75 M(-17.2%)
June 2017
$3.32 M
$731.10 K(+4.7%)
$3.32 M(-3.7%)
Mar 2017
-
$698.10 K(+22.2%)
$3.44 M(+2.0%)
DateAnnualQuarterlyTTM
Dec 2016
-
$571.30 K(-56.6%)
$3.38 M(-8.6%)
Sept 2016
-
$1.32 M(+53.4%)
$3.70 M(+29.5%)
June 2016
$2.85 M(+31.5%)
$858.20 K(+36.2%)
$2.85 M(+11.4%)
Mar 2016
-
$630.20 K(-29.2%)
$2.56 M(+5.3%)
Dec 2015
-
$890.70 K(+87.9%)
$2.43 M(+10.7%)
Sept 2015
-
$474.00 K(-16.4%)
$2.20 M(+1.3%)
June 2015
$2.17 M(+23.5%)
$566.90 K(+13.2%)
$2.17 M(+35.4%)
Mar 2015
-
$500.80 K(-23.7%)
$1.60 M(-22.5%)
Dec 2014
-
$656.20 K(+47.5%)
$2.07 M(+1.0%)
Sept 2014
-
$445.00 K(-54.0%)
$2.05 M(-48.8%)
June 2014
$1.76 M(-55.5%)
-
-
Mar 2014
-
$966.90 K(+52.0%)
$4.00 M(+1.2%)
Dec 2013
$3.95 M(>+9900.0%)
$636.20 K(-14.2%)
$3.95 M(+19.1%)
Sept 2013
-
$741.40 K(-55.2%)
$3.32 M(+28.5%)
June 2013
-
$1.65 M(+79.7%)
$2.58 M(+178.0%)
Mar 2013
-
$920.40 K(>+9900.0%)
$928.80 K(+7976.5%)
Dec 2012
-
$3200.00(-23.8%)
$11.50 K(-40.1%)
Sept 2012
-
$4200.00(+320.0%)
$19.20 K(+1.6%)
June 2012
-
$1000.00(-67.7%)
$18.90 K(-23.5%)
June 2012
$18.90 K(-42.9%)
-
-
Mar 2012
-
$3100.00(-71.6%)
$24.70 K(-2.8%)
Dec 2011
-
$10.90 K(+179.5%)
$25.40 K(-12.7%)
Sept 2011
-
$3900.00(-42.6%)
$29.10 K(-12.1%)
June 2011
$33.10 K(+491.1%)
$6800.00(+78.9%)
$33.10 K(+22.1%)
Mar 2011
-
$3800.00(-74.0%)
$27.10 K(+15.8%)
Dec 2010
-
$14.60 K(+84.8%)
$23.40 K(+125.0%)
Sept 2010
-
$7900.00(+887.5%)
$10.40 K(+316.0%)
June 2010
$5600.00
$800.00(+700.0%)
$2500.00(+47.1%)
Mar 2010
-
$100.00(-93.8%)
$1700.00(+6.3%)
Dec 2009
-
$1600.00
$1600.00

FAQ

  • What is Kintara Therapeutics annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for Kintara Therapeutics?
  • What is Kintara Therapeutics annual SG&A year-on-year change?
  • What is Kintara Therapeutics quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for Kintara Therapeutics?
  • What is Kintara Therapeutics quarterly SG&A year-on-year change?
  • What is Kintara Therapeutics TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for Kintara Therapeutics?
  • What is Kintara Therapeutics TTM SG&A year-on-year change?

What is Kintara Therapeutics annual selling, general & administrative expenses?

The current annual SG&A of KTRA is $5.79 M

What is the all time high annual SG&A for Kintara Therapeutics?

Kintara Therapeutics all-time high annual selling, general & administrative expenses is $9.76 M

What is Kintara Therapeutics annual SG&A year-on-year change?

Over the past year, KTRA annual selling, general & administrative expenses has changed by +$303.00 K (+5.52%)

What is Kintara Therapeutics quarterly selling, general & administrative expenses?

The current quarterly SG&A of KTRA is $2.28 M

What is the all time high quarterly SG&A for Kintara Therapeutics?

Kintara Therapeutics all-time high quarterly selling, general & administrative expenses is $2.79 M

What is Kintara Therapeutics quarterly SG&A year-on-year change?

Over the past year, KTRA quarterly selling, general & administrative expenses has changed by +$1.18 M (+107.07%)

What is Kintara Therapeutics TTM selling, general & administrative expenses?

The current TTM SG&A of KTRA is -$627.48 M

What is the all time high TTM SG&A for Kintara Therapeutics?

Kintara Therapeutics all-time high TTM selling, general & administrative expenses is $10.40 M

What is Kintara Therapeutics TTM SG&A year-on-year change?

Over the past year, KTRA TTM selling, general & administrative expenses has changed by -$632.59 M (-12372.15%)